Why the study?
Does mitral valve repair improve outcomes in patients with significant mitral regurgitation and end-stage cardiomyopathy?
Population
66 patients with significant mitral regurgitation and an ejection fraction below 30%
Design
Cohort
Follow-up
Mean 28+/-18 months
Authors
Loading...
Supports mitral valve repair feasibility in severe MR with end-stage cardiomyopathy; leaves open survival benefit versus medical therapy alone.
Does mitral valve repair improve outcomes in patients with significant mitral regurgitation and end-stage cardiomyopathy?
Mitral valve repair is technically feasible with acceptable perioperative mortality in patients with end-stage cardiomyopathy and severe mitral regurgitation, leading to improvements in ejection fraction and symptoms.
Jan Gummert (2003) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: